As a key enzyme in the metabolism of AMP to ADO, CD73 regulates the balance of purinergic metabolism, which drives a shift from an ATP-induced pro-inflammatory environment to an ADO-driven anti-inflammatory milieu and may dictate the outcome of several pathophysiological events, including autoimmune diseases [10, 11]. This evidence concerns the gene ADO and autoimmune disease.